PURPOSE: The antegrade continence enema (ACE) is used as a means of managing faecal incontinence and constipation with varying outcomes. We aim to evaluate our outcomes of ACEs and identify predictors of outcome. METHODS: A retrospective case-note review of patients ≤16 years of age undergoing an ACE (March 2000-September 2013) was carried out. Data collected included: patient demographics, functional outcomes and complications. Data are quoted as median (range) and compared using Mann-Whitney and Fisher's exact test. Univariate analysis was performed to identify predictors of successful outcomes. P < 0.05 is significant. Successful outcome = total continence/occasional leakage and failed outcome = regular soiling and/or constipation. RESULTS: 111 patients with complete data sets underwent an ACE [59% male, median age = 9.5 years (3.4-16 years)] and median follow-up = 48 months (4 months-11 years 4 months). Underlying diagnoses were idiopathic constipation (n = 68), anorectal malformation (n = 27), neuropathic bowel (n = 7), Hirschsprung disease (n = 5) and gastrointestinal dysmotility (n = 4). Social continence was achieved in 87/111 (78%). Fifteen percent of patients underwent reversal of ACE due to resolution of symptoms. There was no difference in outcomes related to diagnosis, gender, age or follow-up duration. Complication rate was 20.7% (23/111). CONCLUSIONS: The ACE is safe and effective in the management of intractable constipation and soiling. No predictors of outcome were identified.
PURPOSE: The antegrade continence enema (ACE) is used as a means of managing faecal incontinence and constipation with varying outcomes. We aim to evaluate our outcomes of ACEs and identify predictors of outcome. METHODS: A retrospective case-note review of patients ≤16 years of age undergoing an ACE (March 2000-September 2013) was carried out. Data collected included: patient demographics, functional outcomes and complications. Data are quoted as median (range) and compared using Mann-Whitney and Fisher's exact test. Univariate analysis was performed to identify predictors of successful outcomes. P < 0.05 is significant. Successful outcome = total continence/occasional leakage and failed outcome = regular soiling and/or constipation. RESULTS: 111 patients with complete data sets underwent an ACE [59% male, median age = 9.5 years (3.4-16 years)] and median follow-up = 48 months (4 months-11 years 4 months). Underlying diagnoses were idiopathic constipation (n = 68), anorectal malformation (n = 27), neuropathic bowel (n = 7), Hirschsprung disease (n = 5) and gastrointestinal dysmotility (n = 4). Social continence was achieved in 87/111 (78%). Fifteen percent of patients underwent reversal of ACE due to resolution of symptoms. There was no difference in outcomes related to diagnosis, gender, age or follow-up duration. Complication rate was 20.7% (23/111). CONCLUSIONS: The ACE is safe and effective in the management of intractable constipation and soiling. No predictors of outcome were identified.
Authors: J L Graf; C Strear; B Bratton; H T Housley; R W Jennings; M R Harrison; C T Albanese Journal: J Pediatr Surg Date: 1998-08 Impact factor: 2.545
Authors: Elizabeth B Yerkes; Mark P Cain; Shelly King; Timothy Brei; Martin Kaefer; Anthony J Casale; Richard C Rink Journal: J Urol Date: 2003-01 Impact factor: 7.450
Authors: Sebastian K King; Jonathan R Sutcliffe; Bridget R Southwell; Peter G Chait; John M Hutson Journal: J Pediatr Surg Date: 2005-12 Impact factor: 2.545
Authors: E P Athanasakos; K I Kemal; R S Malliwal; S M Scott; N S Williams; Q Aziz; H C Ward; C H Knowles Journal: Br J Surg Date: 2013-05 Impact factor: 6.939
Authors: Iain E Yardley; Satu-Liisa Pauniaho; Colin T Baillie; Rick R Turnock; Pat Coldicutt; Graham L Lamont; Simon E Kenny Journal: J Pediatr Surg Date: 2009-06 Impact factor: 2.545
Authors: Stephen Yang; Michael E Chua; Stuart Bauer; Anne Wright; Per Brandström; Piet Hoebeke; Søren Rittig; Mario De Gennaro; Elizabeth Jackson; Eliane Fonseca; Anka Nieuwhof-Leppink; Paul Austin Journal: Pediatr Nephrol Date: 2017-10-03 Impact factor: 3.714
Authors: Clara Chong; Neil Featherstone; Shazia Sharif; Abraham Cherian; Peter Cuckow; Imran Mushtaq; Paolo De Coppi; Kate Cross; Joseph Curry Journal: Pediatr Surg Int Date: 2016-01-29 Impact factor: 1.827
Authors: Vanesca P A de Arruda; Maria A Bellomo-Brandão; Joaquim M Bustorff-Silva; Elizete Aparecida Lomazi Journal: J Pediatr (Rio J) Date: 2018-10-22 Impact factor: 2.990